Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
17 sept. 2019 16h05 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced that on September 12, 2019, the Compensation Committee of the...
Sientra Reports Second Quarter 2019 Financial Results
08 août 2019 16h01 HE
|
Sientra, Inc.
Record total net sales of $20.5 million in 2Q19, growth of 17% year over year Breast Products net sales of $11.2 million in 2Q19, growth of 19% year over year Record miraDry net sales of $9.3...
Sientra to Report Second Quarter 2019 Financial Results on August 8, 2019
18 juil. 2019 16h30 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that it will release financial results for the second quarter...
Sientra, Inc. Closes $115 Million Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares
07 juin 2019 16h01 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., June 07, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced the closing of its previously...
Sientra Announces Pricing of Upsized Public Offering of Common Stock
04 juin 2019 18h30 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., June 04, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced the upsizing and pricing of its...
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04 juin 2019 07h00 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., June 04, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ( “Sientra” or the “Company”), a medical aesthetics company, today announced that on May 30, 2019, the...
Sientra Commences Public Offering of Common Stock
03 juin 2019 16h02 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that it has commenced an...
Sientra Reports First Quarter 2019 Financial Results
08 mai 2019 16h01 HE
|
Sientra, Inc.
First Quarter 2019 Net Sales of $17.6 million, Growth of 20% year over year Provides 2019 Net Sales Outlook of $79 million to $83 million SANTA BARBARA, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- ...
Sientra to Release First Quarter Financial Results on May 8, 2019
18 avr. 2019 16h15 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company (“Sientra” or the “Company”), announced today that the Company will release its...
Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter
20 mars 2019 16h26 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., March 20, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company (“Sientra" or the “Company”), today announced it has provided an initial response...